+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report by Product (System, Consumables), by Modality (Slow Continuous Ultra-Filtration, Continuous Veno-Venous Hemofiltration, by Region, and Segment Forecasts, 2022-2030

  • ID: 4418817
  • Report
  • March 2022
  • Region: Global
  • 110 Pages
  • Grand View Research

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Medtronic plc
  • Nipro Corporation
  • Nxstage Medical, Inc
  • Toray Medical Co. Ltd.
The global continuous renal replacement therapy market size is anticipated to reach USD 2.6 billion by 2030. The market is expected to expand at a CAGR of 8.5% from 2022 to 2030. The primary driving factors for market growth are the increasing prevalence of congestive heart failure and acute renal failure. COVID-19 is expected to have a positive impact on the market due to the increasing prevalence of acute kidney injury. According to the WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.



Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company's replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.

Continuous Renal Replacement Therapy Market Report Highlights

  • By product, the consumables segment held the largest revenue share of 60.6% in 2021. Although these products are low-priced, it is used repeatedly purchased; hence the market for consumables is the largest as compared to other segments
  • Based on the modality, the Continuous Veno-venous Hemofiltration (CVVH) segment held the largest revenue share of 31.5% in 2021. Fluid overload situations, which are common in acute kidney injury patients in critical care units, are expected to increase, boosting the CVVH market's growth
  • Asia Pacific was the fastest growing market for continuous renal replacement therapy with a growth rate of 9.6%. Various factors are responsible for the region's growth such as technological advancement, growing healthcare infrastructure development as well as and the presence of such a huge patient base in this region


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Continuous Renal Replacement Therapy Market

What is the estimated value of the Global Continuous Renal Replacement Therapy Market?

The Global Continuous Renal Replacement Therapy Market was estimated to be valued at $1.4 Billion in 2022.

What is the growth rate of the Global Continuous Renal Replacement Therapy Market?

The growth rate of the Global Continuous Renal Replacement Therapy Market is 8.5%, with an estimated value of $2.6 Billion by 2030.

What is the forecasted size of the Global Continuous Renal Replacement Therapy Market?

The Global Continuous Renal Replacement Therapy Market is estimated to be worth $2.6 Billion by 2030.

Who are the key companies in the Global Continuous Renal Replacement Therapy Market?

Key companies in the Global Continuous Renal Replacement Therapy Market include B. Braun Melsungen AG, Baxter International, Inc., Fresenius Medical Care AG & Co. Kga, Asahi Kasei Corporation, Nipro Corporation, Toray Medical Co. Ltd. and Medtronic plc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Medtronic plc
  • Nipro Corporation
  • Nxstage Medical, Inc
  • Toray Medical Co. Ltd.

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Product
1.1.2 Modality
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Continuous Renal Replacement Therapy Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing Incidence Of Acute Kidney Injury And Chronic Kidney Diseases Globally
3.5.1.2 Growing Government Initiatives And Recommendations For Efficient Kidney Disease Management
3.5.1.3 Rapid Advancements And Launch Of New Technologies
3.5.2 Market Restraints Analysis
3.5.2.1 High Cost Of Crrt Procedures
3.6 Continuous Renal Replacement Therapy: Market Analysis Tools
3.6.1 Industry Analysis-Porter’s
3.6.2 Swot Analysis, By Pest
3.7 Impact of COVID-19 on Market
Chapter 4 Continuous Renal Replacement Therapy Market: Segment Analysis, By Product, 2017-2030 (USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Continuous Renal Replacement Therapy Market, by Product, 2017 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
4.5.1 System
4.5.1.1 System Market, 2017-2030 (USD Million)
4.5.2 Consumables
4.5.2.1 Consumables market, 2017-2030 (USD Million)
Chapter 5 Continuous Renal Replacement Therapy Market: Segment Analysis, By Modality, 2017-2030 (USD Million)
5.1 Definition and Scope
5.2 Modality Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Continuous Renal Replacement Therapy Market, by Modality, 2017 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
5.5.1 Slow Continuous Ultra-Filtration (Scuf)
5.5.1.1 Slow Continuous Ultra-Filtration (Scuf) Market, 2017-2030 (USD Million)
5.5.2 Continuous Venovenous Hemofiltration (Cvvh)
5.5.2.1 Continuous Veno-venous Hemofiltration (Cvvh) Market, 2017-2030 (USD Million)
5.5.3 Continuous Veno-venous Hemodialysis (Cvvhd)
5.5.3.1 Continuous Veno-venous Hemodialysis (Cvvhd) Market, 2017-2030 (USD Million)
5.5.4 Continuous Veno-venous Hemodiafiltration (Cvvhdf)
5.5.4.1 Continuous Veno-venous Hemodiafiltration (Cvvhdf) Market, 2017-2030 (USD Million)
Chapter 6 Continuous Renal Replacement Therapy Market: Regional Market Analysis, By Product, and By Modality, 2017-2030 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2021 & 2030
6.3 Regional Market Dashboard
6.4 Regional Market Snapshot
6.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
6.6 North America
6.6.1 North America Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.6.2 U.S.
6.6.2.1 U.S. Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.6.3 Canada
6.6.3.1 Canada Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.7 Europe
6.7.1 Europe Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.7.2 U.K.
6.7.2.1 U.K. Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.7.3 Germany
6.7.3.1 Germany Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.7.4 France
6.7.4.1 France Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.7.5 Italy
6.7.5.1 Italy Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.7.6 Spain
6.7.6.1 Spain Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.8 Asia Pacific
6.8.1 Asia Pacific Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.8.2 Japan
6.8.2.1 Japan Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.8.3 China
6.8.3.1 China Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.8.4 India
6.8.4.1 India Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.8.5 Australia
6.8.5.1 Australia Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.8.6 South Korea
6.8.6.1 South Korea Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.9 Latin America
6.9.1 Latin America Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.9.2 Brazil
6.9.2.1 Brazil Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.9.3 Mexico
6.9.3.1 Mexico Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.9.4 Argentina
6.9.4.1 Argentina Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.9.5 Colombia
6.9.5.1 Colombia Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.10 MEA
6.10.1 MEA Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.10.2 South Africa
6.10.2.1 South Africa Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.10.3 Saudi Arabia
6.10.3.1 Saudi Arabia Continuous Renal Replacement Therapy Market, 2017-2030 (USD Million)
6.10.4 UAE
6.10.4.1 UAE Continuous renal replacement therapy market, 2017-2030 (USD Million)
Chapter 7 Continuous Renal Replacement Therapy Market-Competitive Analysis
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 Key Company Market Share Analysis, 2021
7.3.2 Major Deals And Strategic Alliances
7.3.2.1 New Product Launch
7.3.2.2 Expansion
7.3.2.3 Acquisition
7.3.3 MARKET ENTRY STRATEGIES
7.4 Company Profiles
7.4.1 B. BRAUN MELSUNGEN AG
7.4.1.1 Company overview
7.4.1.2 Financial Performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 BAXTER INTERNATIONAL, INC.
7.4.2.1 Company overview
7.4.2.2 Financial Performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 FRESENIUS MEDICAL CARE AG & CO. KGA
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 ASAHI KASEI CORPORATION
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 NIPRO CORPORATION
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 TORAY MEDICAL CO., LTD.
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.7 NXSTAGE MEDICAL, INC
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic initiatives
7.4.8 MEDTRONIC PLC
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America continuous renal replacement therapy market, by country, 2017-2030 (USD Million)
Table 4. North America continuous renal replacement therapy market, by Product, 2017-2030 (USD Million)
Table 5. North America continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 6. U.S. continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 7. U.S. continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 8. Canada continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 9. Canada continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 10. Europe continuous renal replacement therapy market, by country, 2017-2030 (USD Million)
Table 11. Europe continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 12. Europe continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 13. U.K. continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 14. U.K. continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 15. Germany continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 16. Germany continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 17. France continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 18. France continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 19. Italy continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 20. Italy continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 21. Spain continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 22. Spain continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 23. Asia Pacific continuous renal replacement therapy market, by country, 2017-2030 (USD Million)
Table 24. Asia Pacific continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 25. Asia Pacific continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 26. China continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 27. China continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 28. Japan continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 29. Japan continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 30. India continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 31. India continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 32. Australia continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 33. Australia continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 34. South Korea continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 35. South Korea continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 36. Latin America continuous renal replacement therapy market, by country, 2017-2030 (USD Million)
Table 37. Latin America continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 38. Latin America continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 39. Brazil continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 40. Brazil continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 41. Mexico continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 42. Mexico continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 43. Argentina continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 44. Argentina continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 45. Colombia continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 46. Colombia continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 47. Middle East & Africa continuous renal replacement therapy market, by country, 2017-2030 (USD Million)
Table 48. Middle East & Africa continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 49. Middle East & Africa continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 50. South Africa continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 51. South Africa continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 52. Saudi Arabia continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 53. Saudi Arabia continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
Table 54. UAE continuous renal replacement therapy market, by product, 2017-2030 (USD Million)
Table 55. UAE continuous renal replacement therapy market, by modality, 2017-2030 (USD Million)
List of Figures
Fig 1. Continuous renal replacement therapy market segmentation
Fig 2. Market research process
Fig 3. Information procurement
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value-chain-based sizing & forecasting
Fig 7. QFD modeling for market share assessment
Fig 8. Market formulation & validation
Fig 9. Market outlook (2021)
Fig 10. Segment outlook
Fig 11. Strategy framework
Fig 12. Penetration & growth prospect mapping
Fig 13. Consumer behavior analysis
Fig 14. Market driver relevance analysis (Current & future impact)
Fig 15. Market restraint relevance analysis (Current & future impact)
Fig 16. Porter’s five forces analysis
Fig 17. SWOT analysis, by factor (political & legal, economic and technological)
Fig 18. Continuous renal replacement therapy market: Product movement analysis
Fig 19. Segment dashboard
Fig 20. Continuous renal replacement therapy market Product outlook: Key takeaways
Fig 21. System market, 2017 - 2030 (USD Million)
Fig 22. Consumables market, 2017 - 2030 (USD Million)
Fig 23. Continuous renal replacement therapy market: Modality movement analysis
Fig 24. Segment dashboard
Fig 25. Continuous renal replacement therapy market Modality outlook: Key takeaways
Fig 26. Slow continuous ultra filtration (SCUF) market, 2017 - 2030 (USD Million)
Fig 27. Continuous Venovenous Hemofiltration (CVVH) market, 2017 - 2030 (USD Million)
Fig 28. Continuous Venovenous Hemodialysis (CVVHD) market, 2017 - 2030 (USD Million)
Fig 29. Continuous Venovenous Hemodiafiltration (CVVHDF) market, 2017 - 2030 (USD Million)
Fig 30. Regional outlook, 2021 & 2030
Fig 31. Regional market dashboard
Fig 32. Regional marketplace: Key takeaways
Fig 33. North America continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 34. U.S. continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 35. Canada continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 36. Europe continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 37. U.K. continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 38. Germany continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 39. France continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 40. Italy continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 41. Spain continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 42. Asia Pacific continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 43. Japan continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 44. China continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 45. South Korea continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 46. Australia continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 47. India continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 48. Latin America continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 49. Brazil continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 50. Mexico continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 51. Argentina continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 52. Colombia continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 53. MEA continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 54. South Africa continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 55. Saudi Arabia continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 56. UAE continuous renal replacement therapy market, 2017 - 2030 (USD Million)
Fig 57. Company market share analysis, 2021
Fig 58. Market differentiators
Fig 59. Regional network map
Note: Product cover images may vary from those shown
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. Kga
  • Asahi Kasei Corporation
  • Nipro Corporation
  • Toray Medical Co. Ltd.
  • Nxstage Medical, Inc
  • Medtronic plc
Note: Product cover images may vary from those shown

Loading
LOADING...